These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30631400)

  • 1. One in five hepatocellular carcinoma patients in the United States are Hispanic while less than 40% were eligible for liver transplantation.
    Robinson A; Ohri A; Liu B; Bhuket T; Wong RJ
    World J Hepatol; 2018 Dec; 10(12):956-965. PubMed ID: 30631400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Hepatocellular Carcinoma Tumor Stage at Diagnosis in the 1945-1965 Birth Cohort Reflects Poor Use of Hepatocellular Carcinoma Screening.
    Robinson A; Tavakoli H; Liu B; Bhuket T; Wong RJ
    Hepatol Commun; 2018 Sep; 2(9):1147-1155. PubMed ID: 30202827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
    Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
    J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
    Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
    J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry.
    Wong RJ; Devaki P; Nguyen L; Cheung R; Nguyen MH
    Liver Transpl; 2014 May; 20(5):528-35. PubMed ID: 24415542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased long-term survival among patients with hepatocellular carcinoma after implementation of Model for End-stage Liver Disease score.
    Wong RJ; Devaki P; Nguyen L; Cheung R; Cho-Phan C; Nguyen MH
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1534-40.e1. PubMed ID: 24361414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birth cohort-specific disparities in hepatocellular carcinoma stage at diagnosis, treatment, and long-term survival.
    Yan M; Ha J; Aguilar M; Bhuket T; Liu B; Gish RG; Cheung R; Wong RJ
    J Hepatol; 2016 Feb; 64(2):326-332. PubMed ID: 26386160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
    Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
    Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Older Patients With Hepatocellular Carcinoma Have More Advanced Disease, Lower Rates of Treatment, and Lower Survival.
    Yan M; Ha J; Aguilar M; Liu B; Frenette CT; Bhuket T; Wong RJ
    J Clin Gastroenterol; 2017 Apr; 51(4):378-383. PubMed ID: 27380460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
    Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approximately one-half of patients with early-stage hepatocellular carcinoma meeting Milan criteria did not receive local tumor destructive or curative surgery in the post-MELD exception era.
    Devaki P; Wong RJ; Marupakula V; Nangia S; Nguyen L; Ditah IC; Ehrinpreis MN; Nguyen MH
    Cancer; 2014 Jun; 120(11):1725-32. PubMed ID: 24590359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
    Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M
    Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Ethnic Subgroups on Tumor Stage at Diagnosis, Treatment Received, and Long-Term Survival Among Asian Adults With Hepatocellular Carcinoma.
    Yu JR; Wang J; Bhuket T; Liu B; Wong RJ
    J Clin Exp Hepatol; 2019; 9(2):182-190. PubMed ID: 31024200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.
    Zaydfudim VM; Vachharajani N; Klintmalm GB; Jarnagin WR; Hemming AW; Doyle MB; Cavaness KM; Chapman WC; Nagorney DM
    Ann Surg; 2016 Oct; 264(4):650-8. PubMed ID: 27433910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features of hepatocellular carcinoma in Hispanics differ from African Americans and non-Hispanic Whites.
    Venepalli NK; Modayil MV; Berg SA; Nair TD; Parepally M; Rajaram P; Gaba RC; Bui JT; Huang Y; Cotler SJ
    World J Hepatol; 2017 Mar; 9(7):391-400. PubMed ID: 28321275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of hepatocellular carcinoma in Hispanics in the United States.
    El-Serag HB; Lau M; Eschbach K; Davila J; Goodwin J
    Arch Intern Med; 2007 Oct; 167(18):1983-9. PubMed ID: 17923599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.